SIGLEC10, an sialic acid-binding immunoglobulin-like lectin, is closely related to immune cell function, suggesting that sialic acid-modified glycoproteins may play a role in immune evasion and inflammation regulation within the tumor microenvironment (33–35). The gene discussed is SIGLEC10; the disease is neoplasm.